Literature DB >> 12093262

Celecoxib-induced cholestatic hepatotoxicity in a patient with cirrhosis.

Paulo Alegria, Luís Lebre, Cristina Chagas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12093262     DOI： 10.7326/0003-4819-137-1-200207020-00030

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Acute cholestatic hepatitis associated with long-term use of rofecoxib.

Authors:  Georgios I Papachristou; Anthony J Demetris; Mordechai Rabinovitz
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

2.  Late-onset celecoxib-induced combined hepato-nephrotoxicity.

Authors:  James H Tabibian; Neshan Tabibian; David M Kaufman
Journal:  Br J Clin Pharmacol       Date:  2008-03-05       Impact factor: 4.335

3.  Rofecoxib-induced hepatotoxicity: a forgotten complication of the coxibs.

Authors:  Brian Yan; Yvette Leung; Stefan J Urbanski; Robert P Myers
Journal:  Can J Gastroenterol       Date:  2006-05       Impact factor: 3.522

4.  Safety profile of celecoxib as used in general practice in England: results of a prescription-event monitoring study.

Authors:  Deborah Layton; Lynda V Wilton; Saad A W Shakir
Journal:  Eur J Clin Pharmacol       Date:  2004-09       Impact factor: 2.953

5.  Celecoxib-induced cholestatic liver failure requiring orthotopic liver transplantation.

Authors:  Ihab I El Hajj; Shahid M Malik; Hany R Alwakeel; Obaid S Shaikh; Eizaburo Sasatomi; Hossam M Kandil
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.